2-Amino-4-fluorobenzoic acid

We are 2-Amino-4-fluorobenzoic acid CAS:446-32-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2-Amino-4-fluorobenzoic acid
CAS.NO:446-32-2
Synonyms:4-fluoro-2-aminobenzoic acid;
2-Amino-4-fluorobenzoic;
Molecular Formula:C7H6FNO2
Molecular Weight:155.12600
 
Physical and Chemical Properties:
Density:1.43;
Melting point:192-196oC;
Boiling point:318.1oC;
Flash point:146.2oC;
Index of Refraction:1.509;
 
Specification:
Appearance:Off-white to brown crystalline powder
Purity:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate for organic synthesis

2-Amino-4-fluorobenzoic acid


Related News: European companies are the main suppliers of specialty APIs, but due to environmental and cost pressures, APIs have begun to shift to the Asian market.Noopept CAS:157115-85-0 Subsequently, the company launched the drug under the brand names ‘Remo’ and ‘Remozen’.503299-24-9 As a result, the Company’s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy.10-bromobenzo [b] nafto [1,2-d] furano CAS:1256544-20-3 Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country.Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country.

Related Products
Product Name
(NZ)-N-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]hydroxylamine View Details
dibenzo-18-crown-6 View Details
quinoxalin-2-ol View Details
DL-1,2-Hexanediol manufacturer 5-Methyl furfural manufacturer 4-Isopropylthioxanthone manufacturer 4-Bromo-3-nitrobenzotrifluoride manufacturer 1-Phenyl-1,2,3,4-tetrahydroisoquinoline manufacturer